Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-914-1 | CAS number: 15816-71-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-01-23 - 2017-03-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Octanoic acid, compound with dicyclohexylamine (1:1)
- EC Number:
- 239-914-1
- EC Name:
- Octanoic acid, compound with dicyclohexylamine (1:1)
- Cas Number:
- 15816-71-4
- Molecular formula:
- C20H39NO2
- IUPAC Name:
- octanoic acid, compound with dicyclohexylamine (1:1)
- Test material form:
- solid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- Species: Mice CBA/Ca
Source: AnLab Prague, Czech Republic
Number and Sex of Animals: 29 female, non-pregnant and nulliparous animals were used
Age at First Dose: 8-11 weeks
Animal Health: The health condition of animals was examined by a veterinarian
before initiation of the study
Acclimation: The animals were acclimated in identical conditions as during the experiment for 6 days prior to the start of treatment. The acclimation was according to standard operation procedures.
Housing Condition: The animals were housed in polypropylene cages (5 animals per cage) suspended on stainless steel racks, in a room equipped with central air-conditioning. The room temperature was within the range of 22 ± 3°C, relative humidity was within the range of 50 - 60 %. The light regimen was set to a 12-hour light / 12-hour dark cycle The sanitation was performed according to standard operation procedures.
Diet: A laboratory food ssniff (ssniff Spezialdiäten GmbH, Germany) was served ad libitum, each day approximately at the same time. The certificate of analysis is included in the raw data.
Water: The animals received tap water for human consumption. Supply of drinking water was unlimited. The quality of drinking water is periodically monitored (including microbiological control) and recorded; certificate of analysis is included in raw data.
Bedding: Lignocel S3/4, Lufa - ITL GmbH, Germany
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Concentration:
- 10 %, 25 % and 50 % (w/v)
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
All mice (2 mice/group) were observed daily for any clinical signs of toxicity or local irritation at the application site. Body weights were recorded pre-test and prior to the termination (day 6). Both ears of each mouse were assessed for any sign of irritation. Erythema scores were given following Table 1. Ear thickness was measured by a calliper on Day 1 (pre-dose), Day 3 and Day 6. Excessive local skin irritation is indicated by an erythema score ≥ 3 and/or an increase in ear thickness of ≥ 25 %.
MAIN STUDY
Day 1:
Each animal was identified and the body weight was recorded. To the dorsum of each ear 25 µL of the appropriate dilution of the test item, or the vehicle alone was applied.
Days 2 and 3:
The application procedure carried out on day 1 was repeated.
Days 4 and 5: No treatment.
Day 6:
The body weight of each animal was recorded. 250 µL of phosphate-buffered saline (PBS) containing 2 µCi (7.4 x 104 Bq) of 125I-iododeoxyuridine and 10-5 M Ffluorodeoxyuridine wereas injected into all test and control mice via the tail vein.
Five hours later, the animals were sacrificed. The draining auricular lymph nodes from each ear were excised in PBS and weighted.
Preparation of cell suspensions
Cell suspension of lymph node cells from individual animals was prepared by gentle mechanical disaggregation by glass homogenizer. Lymph node cells were centrifuged by 600g at 4C for 10 min. Suspension of cells were precipitated with 5% trichloroacetic acid (TCA) at 4C for 18-20h. Pellets were centrifuged by 2000g at 4C for 5 min., re-suspended in 1 ml TCA and transferred to gamma counting tubes for 125I-counting.
Determination of cellular proliferation (incorporated radioactivity)
Incorporation of 125I-iododeoxyuridine was measured by 125I-counting on Automatic Gamma Counter Wizard2 (Perkin Elmer) as counts per minute (CPM). The incorporation is expressed as disintegrations per minute (DPM)/animal. DPM were calculated according to formula:
CPM
DPM= ------------------------------
absolute detector efficiency
(Absolute detector efficiency for Gamma Counter Wizard2 2470 = 66.73%)
Clinical Observation
Animals were carefully observed once daily for any clinical symptoms, either of local irritation at the application site or of the systemic toxicity. All observations were systematically recorded with individual records being maintained for each animal.
Body Weight
The animal body weights were determined at the start of the test and at the scheduled day of euthanasia of the animals.
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response:
The SI (stimulation index) was obtained by dividing the individual DPM for each treatment group by the incorporation of the individual DPM vehicle control group; this yields a mean SI. A substance is regarded as sensitizer in the LLNA test when SI≥3.
EC3 value, which induce stimulation indices, was determined by linear interpolation of points on dose-response curve, immediately above and below of SI value, according to the equation: EC3=c+[(3-d)/(b-d)]x(a-c)
a – higher concentration, b – SI of higher concentration, c – lower concentration
d – SI of lower concentration
TREATMENT PREPARATION AND ADMINISTRATION: - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 2.3
- Test group / Remarks:
- 10%
- Key result
- Parameter:
- SI
- Value:
- 5.44
- Test group / Remarks:
- 25%
- Key result
- Parameter:
- SI
- Value:
- 5.25
- Test group / Remarks:
- 50%
- Key result
- Parameter:
- EC3
- Value:
- 13.33
Any other information on results incl. tables
The mean Lymph node weight, DPM, SI, EC3 values
|
Lymph node |
Number of |
|
|
|
|
weight (g) |
lymph nodes |
DPM |
SI |
EC3 |
Control |
0.0263 |
10 |
995 |
- |
13.33
|
Positive Control |
0.0570 |
10 |
9076 |
6.37 |
|
Dicyclohexylammoniumoctanoat 10% |
0.0373 |
10 |
2292 |
2.30 |
|
Dicyclohexylammoniumoctanoat 25% |
0.0466 |
10 |
5414 |
5.44 |
|
Dicyclohexylammoniumoctanoat 50% |
0.0425 |
10 |
5224 |
5.25 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- The skin sensitizing potential of Octanoic acid, compound with dicyclohexylamine (1:1) was assessed using the murine local lymph node assay (LLNA), according to OECD Guideline No. 429.
Based on the results of this study, Octanoic acid, compound with dicyclohexylamine (1:1) is considered a skin sensitizer under the condition of this study. - Executive summary:
The skin sensitization potential of Octanoic acid, compound with dicyclohexylamine (1:1)D was evaluated by LLNA method, which was developed on the basis of scientific understanding of the immunological mechanism of skin sensitization.
Because of signs of toxicity in preliminary test, the main study started at concentration of 50%. In our experiments, the test item was applied over three consecutive days, at three concentrations. In the main study all animals survived throughout the test period without showing any clinical signs of toxicity orlocal irritation.In comparison with the control group, the increase inlymph node weight was observedin all treated groups.A similar trend was registered in the evaluation of DPM of the lymph nodes. Calculated SI values in the treated groups were higher than 3 at the concentrations of 25%. The EC3 value is calculated to be 13.33%. As the SI for some treatment dose group is ≥3 and a dose response is observed, the test item is regarded as a potential skin sensitizer.
These results demonstrate that Octanoic acid, compound with dicyclohexylamine (1:1) is a potential skin sensitizer in the Local Lymph Node Assay under the test conditions of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.